Is p53 Haploinsufficient for Tumor Suppression? Implications for the p53+/- Mouse Model in Carcinogenicity Testing

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Toxicologic pathology (Print)

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/019262301753178555PMID 11695551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.

  2001cited by this paper
• Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment

  2000cited by this paper
• Cancer: p53 sends nucleotides to repair DNA

  2000cited by this paper
• Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.

  2000cited by this paper
• Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays.

  2000cited by this paper
• Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.

  2000cited by this paper
• Genetically altered mouse models for identifying carcinogens.

  1999cited by this paper
• Increased tumor cell proliferation in murine tumors with decreasing dosage of wild‐type p53

  1999cited by this paper
• Transponder-Induced Sarcoma in the Heterozygous p53+/- Mouse

  1999cited by this paper
• Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

  1998cited by this paper
• In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.

  1998cited by this paper
• Tumor surveillance via the ARF-p53 pathway.

  1998cited by this paper
• The complexity of p53 modulation: emerging patterns from divergent signals.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Transgenic mice with p53‐responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo

  1997cited by this paper
• Transgenic mouse model for studying the transcriptional activity of the p53 protein: age‐ and tissue‐dependent changes in radiation‐induced activation during embryogenesis

  1997cited by this paper
• Testing for carcinogenicity of pharmaceuticals.

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens.

  1996cited by this paper
• The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia.

  1996cited by this paper
• Effects of genetic background on tumorigenesis in p53‐deficient mice

  1995cited by this paper
• Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

  1995cited by this paper
• Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans.

  1995cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.

  1994cited by this paper
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

  1994cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994cited by this paper
• In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

  1993cited by this paper
• Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

  1990cited by this paper
• Mutation and cancer: statistical study of retinoblastoma.

  1971cited by this paper

• Microbiota does not influence tumor development in two models of heritable cancer

  2025cites this paper
• p53/MDM2 signaling pathway in aging, senescence and tumorigenesis.

  2024cites this paper
• Aging - what it is and how to measure it.

  2023cites this paper
• Microbiota may affect the tumor type but not overall tumor development in two models of heritable cancer

  2023cites this paper
• Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse

  2023cites this paper
• A common pathway to cancer: Oncogenic mutations abolish p53 oscillations.

  2022cites this paper
• Different properties of mammary carcinogenesis induced by two chemical carcinogens, DMBA and PhIP, in heterozygous BALB/c Trp53 knockout mice

  2021cites this paper
• Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of IκBα expression

  2021cites this paper
• DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation

  2021cites this paper
• Genetic and stochastic influences upon tumor formation and tumor types in Li-Fraumeni mouse models

  2020cites this paper
• Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs*12.

  2020cites this paper
• TP53-Deficient Angiosarcoma Expression Profiling in Rat Model

  2020cites this paper
• p53 Is Not Required for High CIN to Induce Tumor Suppression

  2020cites this paper
• Comparative Cytogenetic Analysis of Dog and Human Choroid Plexus Tumors Defines Syntenic Regions of Genomic Loss

  2018cites this paper
• A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models

  2018cites this paper
• B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.

  2018cites this paper
• Spontaneous testicular atrophy occurs despite normal spermatogonial proliferation in a Tp53 knockout rat

  2017cites this paper
• Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations.

  2017cites this paper
• Understanding the role of the PALB2-BRCA1 interaction in tumor suppression

  2017cites this paper
• Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

  2016cites this paper
• Do p53 stress responses impact organismal aging?

  2016cites this paper
• Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells*

  2016cites this paper
• The Role of MDM2 Phosphorylation in P53 Responses to DNA Damage and Tumor Suppression: A Dissertation

  2016cites this paper
• Clinical Pathology of Laboratory Animals

  2016cites this paper
• p53 and rapamycin are additive

  2015cites this paper
• Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas

  2015cites this paper
• Heterozygous p53 knockout mouse model for dehydropyrrolizidine alkaloid‐induced carcinogenesis

  2015cites this paper
• INVESTIGATION OF GENETIC ALTERATIONS IN EMT SUPPRESSOR, DEAR1, THROUGH PAN-CANCER ANALYSIS AND ULTRA-DEEP TARGETED SEQUENCING IN DUCTAL CARCINOMA IN SITU

  2015cites this paper
• Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors

  2014cites this paper
• Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression

  2014cites this paper
• p53 haploinsufficiency and functional abnormalities in multiple myeloma

  2014cites this paper
• Impact of a complex nutraceutical supplement on primary tumour formation and metastasis in Trp53+/- cancer-prone mice.

  2014cites this paper
• The use of genetically modified mice in cancer risk assessment: Challenges and limitations

  2013cites this paper
• Polymorphisms in G-quadruplex regions of the TP53 tumour suppressor gene : Impact on cancer susceptibility and expression of p53 N-terminal isoforms

  2013cites this paper
• Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.

  2013cites this paper
• The Effect of Trp53 Gene-Dosage and Parent-of-Origin of Inheritance on Mouse Gamete and Embryo Function In Vitro1

  2012cites this paper
• Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity

  2012cites this paper
• Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.

  2012cites this paper
• Induction and persistence of abnormal testicular germ cells following gestational exposure to di-(n-butyl) phthalate in p53-null mice.

  2012cites this paper
• Jdp 2 downregulates Trp 53 transcription to promote leukaemogenesis in the context of Trp 53 heterozygosity

  2012cites this paper
• The role of the Suprmam1 locus in responses to ionizing radiation and susceptibility to mammary tumors

  2011cites this paper
• Cancer Genes and Genomics Dominant-Negative Features of Mutant TP 53 in Germline Carriers Have Limited Impact on Cancer Outcomes

  2011cites this paper
• Transgenic animal models in toxicology: historical perspectives and future outlook.

  2011cites this paper
• limited impact on cancer outcomes.

  2011cites this paper
• Dominant-Negative Features of Mutant TP53 in Germline Carriers Have Limited Impact on Cancer Outcomes

  2011cites this paper
• Protecting the hedgerow: p53 and Hedgehog pathway interactions

  2010cites this paper
• Lessons on p53 from Mouse Models

  2010cites this paper
• Chemical induced alterations in p53 signaling.

  2009cites this paper
• Gene and microRNA expression in p53-deficient day 8.5 mouse embryos.

  2009cites this paper
• The role of p53 in virus-induced and multi-step lymphomagenesis

  2009cites this paper
• Timed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression

  2009cites this paper
• Using mice to examine p53 functions in cancer, aging, and longevity.

  2009influential citation
• 20 years studying p53 functions in genetically engineered mice

  2009cites this paper
• The role of p53 in normal development and teratogen-induced apoptosis and birth defects in mouse embryos

  2009cites this paper
• p53-dependent apoptosis in the inhibition of spermatogonial differentiation in juvenile spermatogonial depletion (Utp14bjsd) mice.

  2008cites this paper
• Classical and novel roles of p 53 and prospects for anticancer therapy

  2008cites this paper
• The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo

  2008cites this paper
• Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan‐treated p53+/− mice

  2008cites this paper
• Effect of p53 genotype on gene expression profiles in murine liver.

  2008cites this paper
• P53: Gatekeeper, Caretaker or Both?

  2007cites this paper
• Manipulating the p53 Gene in the Mouse: Organismal Functions of a Prototype Tumor Suppressor

  2007cites this paper
• Analysis of p53 Gene Alterations in Cancer: A Critical View

  2007cites this paper
• Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood.

  2007cites this paper
• Classic and novel roles of p53: prospects for anticancer therapy.

  2007cites this paper
• In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma

  2007cites this paper
• Reconstructing Signal Transduction Pathways

  2007cites this paper
• The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models

  2007cites this paper
• Issues in the Design and Interpretation of Chronic Toxicity and Carcinogenicity Studies in Rodents: Approaches to Dose Selection

  2007cites this paper
• Aspartame: A Safety Evaluation Based on Current Use Levels, Regulations, and Toxicological and Epidemiological Studies

  2007cites this paper
• p53, longevity assurance and longevity suppression

  2006cites this paper
• Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice

  2006cites this paper
• Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency

  2006cites this paper
• Probing p53 biological functions through the use of genetically engineered mouse models.

  2005cites this paper
• Absence of acute apoptotic response to genotoxic carcinogens in p53‐deficient mice is associated with increased susceptibility to azoxymethane‐induced colon tumours

  2005cites this paper
• Chapter 12 ANALISYS OF P 53 GENE AALTERATIONS IN CANCER : A CRITICAL VIEW

  2005cites this paper
• p53 must be competent for transcriptional regulation to suppress tumor formation

  2005cites this paper
• Susceptibility of Heterozygous and Nullizygous p53 Knockout Mice to Chemical Carcinogens: Tissue Dependence and Role of p53 Gene Mutations

  2005cites this paper
• Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemia

  2005cites this paper
• Drosophila melanogaster MNK/Chk2 and p53 Regulate Multiple DNA Repair and Apoptotic Pathways following DNA Damage

  2004cites this paper
• Use of Transgenic Mice in Carcinogenicity Hazard Assessment

  2004cites this paper
• CHAPTER 7 – The Mouse in Preclinical Safety Studies

  2004cites this paper
• Loss of Heterozygosity Occurs via Mitotic Recombination in Trp53+/− Mice and Associates with Mammary Tumor Susceptibility of the BALB/c Strain

  2004cites this paper
• Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.

  2004cites this paper
• Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis

  2003cites this paper
• Use of Transgenic Animals in Regulatory Carcinogenicity Evaluations

  2003cites this paper
• BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.

  2003cites this paper
• Differential gene expression screening uncovers downregulation of the cell cycle regulator BTG2 as an important step in renal tumor biology

  2003cites this paper
• Transgenic tumor models for carcinogen identification: the heterozygous Trp53-deficient and RasH2 mouse lines.

  2003cites this paper
• THE ATTENUATION OF THE P53 RESPONSE TO DNA DAMAGE IN RODENT LIVER PRENEOPLASTIC ENZYME- ALTERED FOCI

  2003cites this paper
• Tumorigenic potential of carbaryl in the heterozygous p53 knockout mouse model.

  2003cites this paper
• Reduction of p53 dosage renders mice hypersensitive to 7, 12-dimethylbenz(alpha) anthracene-induced salivary gland tumorigenesis.

  2003cites this paper
• Preneoplastic and Precancerous Lesions in Rodents: Morphologic and Molecular Characteristics

  2002cites this paper
• p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene.

  2002cites this paper
• Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?

  2002cites this paper
• Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer.

  2002cites this paper